OriginalInvestigation | PulmonaryMedicine
Effect of Physical Activity Coaching on Acute Care and Survival
Among Patients With Chronic Obstructive Pulmonary Disease
A Pragmatic Randomized Clinical Trial
HuongQ.Nguyen,PhD,RN;MarilynL.Moy,MD,MS;In-LuAmyLiu,MS;VincentS.Fan,MD,MPH;MichaelK.Gould,MD,MS;SmitaA.Desai,DO;WilliamJ.Towner,MD;
GeorgeYuen,MD;JanetS.Lee,MS;StacyJ.Park,PhD;AnnyH.Xiang,PhD
Abstract KeyPoints
Question Whatisthereal-world
IMPORTANCE Whileobservationalstudiesshowthatphysicalinactivityisassociatedwithworse
effectivenessofa12-monthcommunity-
outcomesinchronicobstructivepulmonarydisease(COPD),therearenopopulation-basedtrialsto
basedphysicalactivity(PA)coaching
datetestingtheeffectivenessofphysicalactivity(PA)interventionstoreduceacutecareuseor
interventiononreducingall-causeacute
improvesurvival.
careuseanddeathinpatientswitha
historyofachronicobstructive
OBJECTIVE Toevaluatethelong-termeffectivenessofacommunity-basedPAcoaching
pulmonarydisease(COPD)
interventioninpatientswithCOPD.
exacerbation?
DESIGN,SETTING,ANDPARTICIPANTS Pragmaticrandomizedclinicaltrialwithpreconsent Findings Inthismultisite,randomized
randomizationtothe12-monthWalkOn!(WO)interventionorstandardcare(SC).Enrollment clinicaltrialthatincludedapopulation-
occurredfromJuly1,2015,toJuly31,2017;follow-upendedinJuly2018.ThesettingwasKaiser basedsampleof2707patientswith
PermanenteSouthernCaliforniasites.Participantswerepatients40yearsorolderwhohadany COPD,321of1358patientsparticipated
COPD-relatedacutecareuseintheprevious12months;onlypatientsassignedtoWOwere inthePAcoachinginterventionand
approachedforconsenttoparticipateininterventionactivities. increasedPAsignificantly,butthere
werenosignificantdifferencesinthe
INTERVENTIONS TheWOinterventionincludedcollaborativemonitoringofPAstepcounts, all-causeprimaryoutcome(compostite
semiautomatedstepgoalrecommendations,individualizedreinforcement,andpeer/familysupport. measureofall-causehospitalizations,
StandardCOPDcarecouldincludereferralstopulmonaryrehabilitation. observationstays,emergency
departmentvisits,anddeath)at
MAINOUTCOMESANDMEASURES Theprimaryoutcomewasacompositebinarymeasureof 12months.
all-causehospitalizations,observationstays,emergencydepartmentvisits,anddeathusingadjusted
Meaning MostpatientswithaCOPD
logisticregressioninthe12monthsafterrandomization.Secondaryoutcomesincludedself-
exacerbationdidnotengageinPA,and
reportedPA,COPD-relatedacutecareuse,symptoms,qualityoflife,andcardiometabolicmarkers.
thelimitedPAdidnotleadtosignificant
benefitin12-monthhealthcareuse.
RESULTS All2707eligiblepatients(baselinemean[SD]age,72[10]years;53.7%female;74.3%of
whiterace/ethnicity;andbaselinemean[SD]percentforcedexpiratoryvolumeinthefirstsecondof
+
expirationpredicted,61.0[22.5])wererandomlyassignedtoWO(n=1358)orSC(n=1349).The Supplementalcontent
intent-to-treatanalysisshowednodifferencesbetweenWOandSContheprimaryall-cause Authoraffiliationsandarticleinformationare
compositeoutcome(oddsratio[OR],1.09;95%CI,0.92-1.28;P=.33)orintheindividualoutcomes. listedattheendofthisarticle.
Prespecified,as-treatedanalysescomparedoutcomesbetweenallSCand321WOpatientswho
participatedinanyinterventionactivities(23.6%[321of1358]uptake).Theas-treated,propensity
score–weightedmodelshowednonsignificantpositiveestimatesinfavorofWOparticipants
comparedwithSConall-causehospitalizations(OR,0.84;95%CI,0.65-1.10;P=.21)anddeath(OR,
0.62;95%CI,0.35-1.11;P=.11).MoreWOparticipantsreportedengaginginPAcomparedwithSC
(47.4%[152of321]vs30.7%[414of1349];P<.001)andhadimprovementsinthePatient-Reported
(continued)
OpenAccess.ThisisanopenaccessarticledistributedunderthetermsoftheCC-BYLicense.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 1/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
Abstract(continued)
OutcomesMeasurementInformationSystem10physicalhealthdomainat6months.Therewereno
groupdifferencesinothersecondaryoutcomes.
CONCLUSIONSANDRELEVANCE ParticipationinaPAcoachingprogrambypatientswithahistory
ofCOPDexacerbationswasinsufficienttoeffectimprovementsinacutecareuseorsurvivalinthe
primaryanalysis.
TRIALREGISTRATION ClinicalTrials.govidentifier:NCT02478359
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657
Introduction
Chronicobstructivepulmonarydisease(COPD)isthefourthleadingcauseofdeathintheUnited
States.1Observationalstudies2-8consistentlyshowthatphysicalinactivityisassociatedwith
increasedhospitalizationsanddeath.Moreover,ithaspreviouslybeenshownthathospitalized
patientswithCOPDwhoengagedinphysicalactivity(PA)beforetheindexadmissionhada34%
lowerriskof30-dayreadmissioncomparedwithinactivepatients.9
Despitetheunequivocalevidencethatpulmonaryrehabilitation(PR)improvespatient-
centeredoutcomes,10,11participationremainsdismalatapproximately5%12,13duetopersistent
barriers.14,15Healthsystemsneedalternativeapproachestoachievemorepatient-centeredcare,
withbetteroutcomesatlowercost,forthemajorityofpatientswhoarenotabletoparticipateinPR,
especiallyinlightofcurrentnationalPAguidelines16andcontinuedpressuretoreduce
readmissions.17Smallstudies18-24ofPAinterventionsshowedpositiveshort-termtomedium-term
improvementsinPA.Thereal-worldandlong-termeffectivenessofinterventionstoincreasePAand
positivelyalterhealthcareuseinalargerepresentativesampleofolderadultsathighriskfor
recurrentCOPDexacerbationsremainsunknown.
Toaddressthisgap,weconductedapragmaticrandomizedclinicaltrialtodeterminethe
effectivenessofa12-monthcommunity-basedPAcoachingprogram(WalkOn![WO])thatwas
designedtobegeneralizable,scalable,andsufficientlyflexibletomeettheneedsofalargediverse
sampleofpatientswithahistoryofCOPDexacerbations.TheWOinterventionwasdesignedbased
onlearningsfromaseriesofcollectivestudies24-27bymembersoftheinvestigativeteamthatwere
informedbyearlyanddeepengagementwithpatientstakeholdersandwasgroundedinsocial
cognitive28andself-regulation29,30theoriesandcoreprinciplesofmotivationalinterviewing.31We
hypothesizedthattheWOinterventionwouldincreasePAandconsequentlyreducefutureacute
careuseanddeathinpatientswhohavehadapreviousCOPDexacerbation.
Methods
StudyDesignandSetting
Thispragmaticrandomizedclinicaltrialcomparedtheeffectivenessofa12-monthPAintervention
withstandardcare(SC)inpatientswithCOPD.Writteninformedconsentwasobtainedonlyfrom
patientswhowererandomizedtotheWOintervention.Theresearchquestion,design,andmethods
arealignedwithmethodologicalstandardsforpragmatictrials.32,33Thisstudywasapprovedbythe
KaiserPermanenteSouthernCaliforniaInstitutionalReviewBoard.Thestudytookplaceat8medical
centerswithinalargeintegratedhealthsystem.ThisstudyfollowedtheConsolidatedStandardsof
ReportingTrials(CONSORT)reportingguideline.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 2/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
StudyPopulation
English-speakingandSpanish-speakingpatientswithaCOPD-relatedhospitalization,emergency
departmentvisit,orobservationstayintheprevious12monthswereidentifiedfromelectronic
medicalrecords(EMRs).PatientswereautomaticallyexcludediftheadministrativeandclinicalEMR
datashowedthattheyhadthefollowingcharacteristics:theywereyoungerthan40years;theyhad
aforcedexpiratoryvolume/forcedvitalcapacity(FEV/FVC)ratioexceeding0.70;theywere
1
dischargedtohospiceortoanotheracute,postacute,orlong-termcarefacility;theywere
nonambulatoryatadmissionordischarge;theyhadAlzheimerdisease,dementia,ormetastatic
cancer;theyweremorbidlyobese(bodymassindex[calculatedasweightinkilogramsdividedby
heightinmeterssquared]>40);ortheyhadcompletedPRinthelast6months.Nomedicalrecord
reviewsorfurtherscreeningswereconducted.Eligiblepatientswereidentifiedandrandomizedfor
thestudyfromJuly1,2015,toJuly31,2017,andwerefollowedupthroughJuly2018.Thesetting
wasKaiserPermanenteSouthernCaliforniasites.
Randomization
Atotalof2707eligiblepatientswererandomlyassigned1:1totheWOinterventionorSC,stratifiedby
medicalcenter,timefromCOPDacutecareevent(<6vs(cid:2)6months),self-reportedPAobtainedfrom
theexercisevitalsign34(inactivevsactive),andmedianage(<72vs(cid:2)72years)byrandompermuted
blockrandomization.PatientsrandomizedtoWOreceivedarecruitmentletterandstudybrochure
viapostalmailandwerefollowedupbytelephoneatleast10businessdaysafterthemailingby
existingclinicalstaff(respiratorytherapistswhoservedasthePAcoaches)toassesstheirinterestin
WO.Followingasingle-consent,encouragementdesign,35,36onlythoseassignedtoWOwere
approachedforwrittenconsenttoparticipateininterventionactivities.Therefore,2groupswere
formedwithinWO,namely,WOparticipantsandWOnonparticipants.PatientsassignedtoSCwere
notcontactedaboutthestudyexceptforarandomsubgroupwhowereinvitedtocompletesurveys
during12months.Detailedstudymethodsandimplementationlearningshavebeenpublished.37,38
Thetrialprotocol,includingthescientificrationaleforthestudydesign,isavailableinSupplement1.
StudyInterventions
TheWOinterventionincludedcollaborativemonitoringofPAstepcounts,semiautomatedstepgoal
recommendations,individualizedreinforcement,andpeer/familysupport,withbuilt-inflexibilityto
accommodatethediversepreferencesandneedsofpatients,aswellasanticipatedimplementation
constraints.WalkingwaspromotedasaprimarymodeofPAbecausealmost90%ofactivitiesthat
patientswithCOPDengageinareambulatoryinnatureandwalkingisasafeandaccessibleform
ofPA.39
TheWOparticipantsweresentabaselineprevisitpacketthatincludedaconsentform,activity
sensortowearfor7daysbeforethevisit,andasurveypacket(measuresaredescribedintheStudy
Outcomessubsection).Duringthebaselinevisit,thecoachreviewedthesurveyresponses,baseline
PA,andperformanceona6-minutewalktesttocollaborativelydesignanindividualizedPAprogram
forthepatient,startingwithaninitialstepgoalforthefirstweek.
Patientsreceived4weeklycoachingphonecallsduringweeks1through5toreinforceor
readjustthePAplanasneeded.OutreachbythePAcoachesfortheremaining11monthswere
individualizedandtargetedaccordingtopatients’progresswiththeirwalkingprogram,technical
difficulties,orautomatedtriggersfromthestudydashboardbasedondatasubmittedbypatients.
Dependingonwhetherpatientschosetousealow-techorinternet-enabledactivitydevice,they
uploadedorreportedtheirPAandsymptomsonaweeklybasisviaaninteractivephonevoice
responsesystemorwebinterface.Stepgoalrecommendationswereprovidedbytherespective
systems.Patientswerealsoencouragedtoattendmonthlygroupsupportmeetingswiththeirpeer/
familycaregivers.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 3/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
ComparisonGroup
TheSCpatientscontinuedtoreceivetheirroutinecareandhadaccesstoallhealthservicesin
accordancewiththeirhealthplan.Patientsreceivednoinstructionstoexerciseandwerenot
contactedaboutthetrialexceptforarandomlyselectedsubgroup(n=537)tocompletesurveysfor
comparisonwithWOparticipants.
StudyOutcomes
Theprimaryoutcomewasacompositebinarymeasureofanyall-causehospitalizations,observation
stays,emergencydepartmentvisits,anddeath.SecondaryoutcomesincludedCOPD-relatedacute
careuse,cardiometabolicmarkers(bloodpressure,glycatedhemoglobin,andlipids),andself-
reportedPA.34Follow-uptimewas12monthsfromthedateofrandomization.Theseoutcomeswere
availableforallpatientsfromtheEMRs.Additionalsecondaryoutcomesincludedthefollowing:
symptoms(COPDAssessmentTest),40depression(PatientHealthQuestionnaire8),41anxiety
(GeneralizedAnxietyDisorder7),42health-relatedqualityoflife(Patient-ReportedOutcomes
MeasurementInformationSystem10[PROMIS-10]),43andsatisfactionwiththeprogramforasubset
ofthesample.ThesedatawereobtainedfrommailedsurveysforallWOparticipantsandarandomly
selectedsubsetofSCpatientsatbaseline,6months,and12months.
SampleSizeandStatisticalAnalysis
Samplesizewascalculatedbasedonestimatesofacutecareuseanddeathfromprevious
studies9,44-46andwiththeassumptionthatapproximately50%ofthepatientsassignedtoWO
wouldparticipateintheintervention.Allowingfora15%disenrollmentfromthehealthplanand
2-tailedα=.05,weanticipatedthatbyenrollingatotalof1650patientswewouldhave80%power
todetectanabsolutereductionof7%intheprimarycompositeoutcome(70%vs63%).Wereached
theenrollmenttargetafter12months,buttheparticipationrateremainedlowat23.5%(147of625).
Thedataandsafetymonitoringboardapprovedarevisedpowercalculationbasedonaprojected
accrualof2700patientsthroughtheendoftheoriginal24-monthrecruitmenttimelinetodetecta
smallerdifferenceof5.5%(seeeMethodsinSupplement2).
Theprimaryanalysesfollowedtheintent-to-treat(ITT)principlesuchthatallrandomized
patientsregardlessofparticipationwereincluded.Follow-uptimewas12monthsfromthedateof
randomization.Secondaryanalysesincludedprespecified,as-treatedanalysesinwhichpatientswho
participatedinWOwerecomparedwithSC,andfollow-uptimewas2to12monthsfromthedateof
randomization.Thefirst2monthsafterrandomizationwereexcludedbecauseitwasexpectedthatit
wouldtakeapproximately2monthsfromthedateofrandomizationtostarttheintervention.
Therefore,onlypatientswhowerefollowedupforatleast2monthsacrossbotharmsfromthedate
ofrandomizationwereeligiblefortheas-treatedanalysis.
Fortheinterventioneffectsonoutcomes,prespecifiedanalysesusedadjustedlogistic
regressionastheprimaryapproachforanyoccurrenceoftheoutcomeswithin12monthsandused
survivalanalysisasthesecondaryapproachfortimetothefirstoccurrenceofeachoutcome.
DisenrollmentrateswereslightlyhigherinSCvsWO(7.9%[107of1349]vs4.8%[65of1359]).For
patientswhodisenrolledfromthehealthplan,databeforedisenrollmentwereused,andtheshorter
durationoffollow-upwasincorporatedintothesurvivalanalysisforallpatients.Allpatientshaddata
onprimaryoutcomesafterrandomization.Fortheas-treatedanalysis,stabilized(standardized
difference,<0.1)propensityscoreinverseprobabilityoftreatmentweighting47wasusedtobalance
baselinecharacteristicsbetweenpatientswhoparticipatedinWOandtheSCgroup.Thepropensity
ofbeingaWOparticipantwascalculatedusingalogisticregressionmodelofbaseline
sociodemographics,healthbehaviors,diseaseseverity,comorbidities,inhalers/medications,health
careuseintheprioryear,andstudysite.
Theapriorithresholdforstatisticalsignificancewasa2-sidedP<.05.Resultsforthesecondary
analysesshouldbeinterpretedasexploratoryduetomultiplecomparisons.Allanalyseswere
conductedusingSAS,version9.4forWindowsstatisticalsoftware(SASInstituteInc).
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 4/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
Results
PatientFlowandBaselineCharacteristics
Atotalof2707patients(baselinemean[SD]age,72[10]years;53.7%female;74.3%ofwhiterace/
ethnicity;andbaselinemean[SD]forcedexpiratoryvolumeinthefirstsecondofexpiration(FEV%)
1
predicted,61.0[22.5])wereidentifiedfromtheEMRsandrandomizedtoWO(n=1358)orSC
(n=1349).Only321of1358patients(23.6%)randomizedtoWOconsentedtoparticipateinthe
interventioncomponentsandcompletedbaselinesurveys(Figure).Intotal,471of1358patients
(34.6%)expressednointerestintheWOprogram.Anadditional313of1358patients(23.0%)
passivelydeclinedtoparticipate(patientswhodidnotreturnourtelephonecallsdespite3contacts).
Atotalof268of537randomlysampledSCpatients(49.9%)completedbaselinesurveys.Baseline
characteristicsweresimilarbetweenallrandomizedWOandSCpatients(Table1andeTable1in
Supplement2).InthoserandomizedtoWO,thereweresignificantbaselinedifferencesbetweenWO
participantsvsnonparticipants(fewercurrentsmokers,greateruseoflong-actinginhalers,fewer
comorbidities,fewerall-causeemergencydepartmentvisits,moreoutpatient-treatedCOPD
exacerbations,andgreateruseofspecialtycare).
WOInterventionProcessMeasures,PA,andSatisfaction
Approximately83.3%(264of317)ofWOparticipantscompletedatleast4reinforcementtelephone
callswiththecoachesinthefirst5weeks(eTable2inSupplement2).Thecoaches’documentation
showedthattheycontactedand/orreviewedparticipants’dataonthestudydashboardamedianof
12timesduringweeks6through52.Almostone-quarter(72of317[22.7%])oftheparticipants
experiencedtechnicalchallengeswiththeiractivitysensors,requiringatleast1replacement,and
15.5%(50of321)chosenottouseanyofthestudy-issueddevices.Lessthanhalfoftheparticipants
(n=104of245)attendedatleast1optionalmonthlygroupvisit.Participantswhocompletedthe
6-monthand12-monthsurveysprovidedfavorableratingsoftheprogram,withthevastmajority
reportingthatitwaseasytofitintotheirlifestyle(93.2%[165of177]onthe6-monthsurveyand
97.1%[135of139]onthe12-monthsurvey)andthattheywouldrecommendtheprogramtoothers
(97.8%[175of179]onthe6-monthsurveyand99.3%[138of139]onthe12-monthsurvey).
Stepcountsfromanyofthe3activitysensorsduring12monthsshowedthatparticipantswith
higherstepcountsatbaseline((cid:2)5000stepsperday)tendedtodecline,whereasthosewithlower
stepcountsatbaseline(<5000stepsperday)remainedsteady(eFigure1inSupplement2).
Measuresofself-reportedPA(theexercisevitalsignfromtheEMRs)inthe12monthsafter
randomizationwerenotsignificantlydifferentbetweenWOandSCgroupsintheITTanalysis
(Table2).However,therewasahigherpercentageofWOparticipantsengaginginanyPA(47.4%[152
of321]vs30.7%[414of1349];P<.001)ormeetingrecommendedPAlevels(21.5%[69of321]vs
12.7%[171of1349];P<.001)comparedwithSC.
PrimaryITTFindingsforAcuteCareUseandDeath
Forallrandomizedpatients,therewasnosignificantdifferenceintheprimarycompositeoutcomeof
all-causehospitalizations,observationstays,emergencydepartmentvisits,anddeathbetweenWO
andSCinthe12monthsafterrandomization(oddsratio[OR],1.09;95%CI,0.92-1.28;P=.33)
(Table3).Therewerealsonobetween-groupdifferencesintheindividualprimaryoutcomesor
COPD-relatedacutecareuse(OR,1.10;95%CI,0.93-1.31;P=.26).Time-to-first-eventmodels
similarlyshowednodifferencesbetweengroups(eTable3andeFigure2inSupplement2).Therate
offallswithinjurieswassimilarbetweengroups.Prespecifiedinteractionteststoassesswhetherthe
interventioneffectsdifferedbybaselinemorbidities,levelofsocialsupport,race/ethnicity,age,sex,
andinternetaccessdidnotidentifysignificantsubgroupeffects.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 5/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
As-TreatedFindingsforAcuteCareUseandDeath
During10monthsoffollow-up,therewerenon–statisticallysignificantpositiveestimatesinfavorof
WOparticipantscomparedwithallSCpatientsonall-causehospitalizations(OR,0.84;95%CI,0.65-
1.10;P=.21)anddeath(OR,0.62;95%CI,0.35-1.11;P=.11)(Table3).Adjustedtime-to-first-event
analysesshowedsimilarestimates,withsignificantgroupdifferencesinobservationstays(hazard
ratio,0.72;95%CI,0.53-0.98;P=.04)(eTable3andeFigure3inSupplement2).
Figure.CONSORTPatientFlow
Patients with a COPD-related hospitalization, emergency department
visit, or observation stay in the previous 12 mo and meet all other
inclusion/exclusion criteria identified from the EMRs
2707Randomized
1358Physical activity coaching 1349Standard care (no contact
(Walk On!) about trial [data only])
908Decline reasons 450Agreed to participate 537Random sample approached
292Not interested to complete surveys
272Unable to reach 129Decline reasons
1 7 5 1 1 157 1 2 8 3 1 6 6T T A L P D D Ho o a ul e i or sco o l c se emk e paf b n ar io odu r ca sf onys ei e l ly at /e d/ lr r pei x a yl adel n
l
rr s f lec irp ahi oos ta mi irn vbt eg a i Kl t i cPtio aa rn t eion 4 3 2 11 3 8 8 5 1 1 2U N T T A D D Lo o al i en o r s co o cta e e
k
eb af bi n n ar ol du rae t s foyse i e t l ly tr e d/ lo ree i x
a
l dsr el ne t r sfea c r pdc i o osh mi rn
t
g aK tP
ion
269D 21 4ec 8 3 2 1 1 4lin U N T D T Oo oe en o
t
o o hctar ee eb f bin ra arl uaes t s se io et l yr d/n o e is lsr le tea dch
10Other
321Completed baseline visit 268Completed baseline surveys
320Completed surveys
123Missing survey reasons
62Lost to follow-up
12Survey not sent due
to late start
75Missing survey reasons
17Too frail/ill 62Lost to follow-up
4Hospice/palliative
10Deceased
care
9Deceased 3No longer interested
10No longer interested
5Too busy
2Disenrolled from KP
2Already exercising
1976-mo survey data 1936-mo survey data
129Missing survey reasons
64Lost to follow-up
19Too frail/ill 94Missing survey reasons
5Too busy 60Lost to follow-up
11Deceased
17Survey not sent
19No longer interested 4No longer interested
5Disenrolled from KP 13Deceased
2Already exercising 223Missing primary outcome
4Hospice/palliative
reasons
care 107Disenrolled from KP
180Missing primary 116Deceased
outcome reasons
65Disenrolled from KP
115Deceased
12-mo 12-mo
1178Primary outcome 1126Primary outcome
191Survey data 174Survey data
CONSORTindicatesConsolidatedStandardsofReportingTrials;COPD,chronicobstructivepulmonarydisease;EMRs,electronicmedicalrecords;andKP,KaiserPermanente.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 6/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
Table1.BaselineSampleCharacteristicsa
Participants,No.(%) Participants,No.(%)
PValuefor
Total StandardCare WO PValuefor WO-P WO-Non-P WO-Pvs
Characteristic (N=2707) (n=1349) (n=1358) SCvsWO (n=321) (n=1037) WO-Non-P
Age,mean(SD),y 72(10) 72(10) 72(10) .98 72(9) 73(11) .12
Female 1455(53.7) 739(54.8) 716(52.7) .28 175(54.5) 541(52.2) .46
Maritalstatus .36
Partnered 1343(49.6) 677(50.2) 666(49.0) .57 163(50.8) 503(48.5)
Education
Collegedegreeorhigher 665(24.6) 329(24.4) 336(24.7) 79(24.6) 257(24.8)
Somecollege 869(32.1) 432(32.0) 437(32.2) .95 105(32.7) 332(32.0) .99
Highschoolorless 1154(42.6) 579(42.9) 575(42.3) 137(42.7) 438(42.2)
Medianhouseholdincome
<$50000 1236(45.7) 616(45.7) 620(45.7) 145(45.2) 474(45.7)
.99 .76
≥$50000 1452(53.6) 724(53.7) 728(53.6) 176(54.8) 553(53.3)
Race/ethnicity
AmericanIndian/AlaskaNative 8(0.0) 4(0.0) 4(0.0) 1(0.0) 3(0.0)
Asian 140(5.2) 59(4.4) 81(6.0) 16(5.0) 65(6.3)
Black/AfricanAmerican 375(13.9) 188(13.9) 187(13.8) 41(12.8) 146(14.1)
Hawaiian/PacificIslander 19(0.7) 6(0.0) 13(0.9) .24 2(0.6) 11(1.0) .31
White 2010(74.3) 1021(75.7) 989(72.8) 245(76.3) 744(71.7)
Multirace/multiethnicity 7(0.0) 4(0.0) 3(0.0) 2(0.6) 1(0.0)
Other/unknown 148(5.4) 67(5.0) 81(6.0) 14(4.4) 67(6.5)
Smokingstatus
Never 331(12.2) 162(12.0) 169(12.4) 43(13.4) 126(12.2)
Former 1868(69.0) 933(69.2) 935(68.9) .85 242(75.4) 693(66.8) .002
Current 481(17.8) 243(18.0) 238(17.5) 34(10.6) 204(19.7)
Spirometry,mostrecent
No. 2036 996 1040 269 771
FEV /FVC,mean(SD) 55.1(14.3) 54.8(14.7) 55.4(13.9) .36 53.5(13.9) 56.0(13.9) .009
1
FEV %predicted,mean(SD) 61.0(22.5) 60.0(21.9) 62.1(23.1) .05 59.3(22.1) 63.1(23.3) .02
1
GOLDI,≥80% 406(19.9) 185(18.6) 221(21.3) 49(18.2) 172(22.3)
GOLDII,50%to<80% 857(42.1) 417(41.9) 440(42.3) 109(40.5) 331(42.9)
.29 .14
GOLDIII,30%to<50% 563(27.7) 288(28.9) 275(26.4) 85(31.6) 190(24.6)
GOLDIV,<30% 131(6.4) 69(6.9) 62(6.0) 16(5.9) 46(6.0)
Medications
Long-actingβ-2agonist 1646(60.8) 846(62.7) 800(58.9) .04 212(66.0) 588(56.7) .01
Long-actinganticholinergic 1422(52.5) 702(52.0) 720(53.0) .58 198(61.7) 522(50.3) .002
LAMAandICS 1244(46.0) 631(46.8) 613(45.1) .40 170(53.0) 443(42.7) .004
LABAandICS 1641(60.6) 844(62.6) 797(58.7) .04 210(65.4) 587(56.6) .02
Long-termsystemiccorticosteroids 243(9.0) 131(9.7) 112(8.2) .19 31(9.7) 81(7.8) .36
Oxygenuse 1059(39.1) 550(40.8) 509(37.5) .08 125(38.9) 384(37.0) .54
CharlsonComorbidityIndex,mean(SD) 3.7(2.3) 3.7(2.2) 3.7(2.3) .38 3.4(2.2) 3.8(2.3) .009
Heartfailure 805(29.7) 398(29.5) 407(30.0) .79 78(24.3) 329(31.7) .01
Pulmonaryhypertension 143(5.3) 70(5.2) 73(5.4) .83 14(4.4) 59(5.7) .36
Type1ortype2diabetes 873(32.2) 456(33.8) 417(30.7) .08 100(31.2) 317(30.6) .84
Depression 741(27.4) 361(26.8) 380(28.0) .48 86(26.8) 294(28.4) .59
Anxiety 742(27.4) 383(28.4) 359(26.4) .25 80(24.9) 279(26.9) .48
Chronicpain 545(20.1) 273(20.2) 272(20.0) .89 63(19.6) 209(20.2) .84
HealthCareUseinPriorYear
Allcause
Hospitalizations 1437(53.1) 735(54.5) 702(51.7) .15 166(51.7) 536(51.7) .99
Observationstays 786(29.0) 394(29.2) 392(28.9) .85 84(26.2) 308(29.7) .22
Emergencydepartmentvisits 2089(77.2) 1050(77.8) 1039(76.5) .41 229(71.3) 810(78.1) .01
(continued)
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 7/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
Table1.BaselineSampleCharacteristicsa(continued)
Participants,No.(%) Participants,No.(%)
PValuefor
Total StandardCare WO PValuefor WO-P WO-Non-P WO-Pvs
Characteristic (N=2707) (n=1349) (n=1358) SCvsWO (n=321) (n=1037) WO-Non-P
COPD-related
Hospitalizations 1107(40.9) 568(42.1) 539(39.7) .16 134(41.7) 405(39.1) .43
Observationstays 480(17.7) 243(18.0) 237(17.5) .66 50(15.6) 187(18.0) .29
Emergencydepartmentvisits 1531(56.6) 766(56.8) 765(56.3) .70 173(53.9) 592(57.1) .25
Outpatient-treatedCOPD 1902(70.3) 966(71.6) 936(68.9) .13 246(76.6) 690(66.5) <.001
exacerbations
Abbreviations:COPD,chronicobstructivepulmonarydisease;FEV%,forcedexpiratory aBaselinevalueswereobtainedinthe12monthsbeforethecohortselection/
1
volumeinthefirstsecondofexpiration;FEV/FVC,ratioofforcedexpiratoryvolumein randomizationdate;educationandmedianhouseholdincomewerebasedon
1
thefirstsecondofexpirationoverforcedvitalcapacity;GOLD,GlobalInitiativefor censusdata.
ObstructiveLungDisease;ICS,inhaledcorticosteroids;LABA,long-actingβ-2agonist;
LAMA,long-actinganticholinergic;SC,standardcare;WO,WalkOn!;WO-P,WalkOn!
participants;WO-Non-P,WalkOn!nonparticipants.
Table2.ChangesinPhysicalActivityDuring12MonthsAfterRandomization
Participants,No.(%) AdjustedPValues
StandardCare(n=1349) WO(n=1358) WO-P(n=321)
SCvs SCvs
ExerciseVitalSigna Baseline 12mo Baseline 12mo Baseline 12mo WOb WO-Pc
Inactive,0min/wk 890(66.0) 819(60.7) 911(67.1) 808(59.5) 208(64.8) 162(50.5)
Insufficientlyactive,1-149min/wk 262(19.4) 243(18.0) 245(18.0) 268(19.7) 67(20.9) 83(25.9) .34 <.001
Active,≥150min/wk 160(11.9) 171(12.7) 174(12.8) 182(13.4) 43(13.4) 69(21.5)
Missingd 37(2.7) 116(8.6) 28(2.1) 100(7.4) 3(0.9) 7(2.2)
Anyphysicalactivity
0min/wk 927(68.7) 935(69.3) 939(69.1) 908(66.9) 211(65.7) 169(52.6)
.16 <.001
>0min/wk 422(31.3) 414(30.7) 419(30.9) 450(33.1) 110(34.3) 152(47.4)
Meetphysicalactivityguidelines
0-149min/wk 1189(88.1) 1178(87.3) 1184(87.2) 1176(86.6) 278(86.6) 252(78.5)
.73 <.01
≥150min/wk 160(11.9) 171(12.7) 174(12.8) 182(13.4) 43(13.4) 69(21.5)
Abbreviations:SC,standardcare;WO,WalkOn!;WO-P,WalkOn!participants. cAs-treatedmultinomiallogisticregressionanalysesusedstabilizedpropensityscore
aExercisevitalsignvaluesincludeallavailabledatainthe12monthsbeforeand12 inverseprobabilityoftreatmentweightingtobalancebaselinecharacteristics
monthsaftertherandomizationdateandaresummarizedasthemedianor (sociodemographics,healthbehaviors,diseaseseverity,comorbidities,inhalers/
modalvalue. medications,clinicalbiomarkers,andhealthcareuseintheprioryear)between
patientswhoparticipatedinWalkOn!andtheSCgroup.
bIntent-to-treatmultinomiallogisticregressionanalysesadjustedforage,forced
expiratoryvolumeinthefirstsecondofexpirationpredicted,CharlsonComorbidity
dMissing12-month,postrandomizationexercisevitalsignforSCandWO(n=216)due
Index,oxygenuse,hospitalizationforchronicobstructivepulmonarydiseaseinthe tonothavinganencounterduringtheyear(85[39.4%])orexercisevitalsignnot
previous12months,outpatient-treatedchronicobstructivepulmonarydisease capturedduringanyencounter(131[60.6%]).
exacerbationintheprevious12months,lengthoftimesinceacutecareuseto
randomization,useoflong-actingβ-2agonistorinhaledcorticosteroids,physical
activitylevel,andstudysite.
SecondaryOutcomes
TherewerenodifferencesbetweenWOparticipantsandSCsurveyrespondersonthebaselineto
6-monthor12-monthchangesintheCOPDAssessmentTest,PatientHealthQuestionnaire8,or
GeneralizedAnxietyDisorder7.ExceptionswerethePROMIS-10physicalhealthdomain(effectsize,
0.25;95%CI,0.05-0.45;P=.01)andsedentarytime(effectsize,−0.26;95%CI,−0.48to−0.04;
P=.02)at6months(Table4).Therewerenosignificantgroupdifferencesincardiometabolic
markersforboththeas-treatedanalysesandtheITTanalyses(eTable4inSupplement2).
Discussion
Inthismultisitepragmaticrandomizedclinicaltrial,a12-monthcommunity-basedPAcoaching
interventionhadnoeffectontheprimarycompositeoutcomeofall-causeacutecareuseanddeath
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 8/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
inpatientsathighriskforrecurrentCOPDexacerbations.Thelackofeffectsisatleastpartly
attributabletothesuboptimaluptake,withonlyone-quarter(321of1358)oftherandomized
patientsparticipatingintheintervention,thelowinterventionintensity,andthereduced
engagementduringthe12months.Theprespecified,as-treatedanalyses,whichincludedonly
patientswhoparticipatedinanyWOinterventioncomponent,showednonsignificantestimates
favoringWOforreducedacutecareuseanddeathcomparedwithcontrols.
ThenullresultsfromourITTanalysesarenotverydifferentfromthoseof2recent,
multicomponentCOPDself-managementstudies.48,49Whilebothstudiesshowedshort-term
reductionsinCOPD-relatedhospitalizationsand/oremergencydepartmentvisitsat6months,
neithershowedapersistenteffectat12months.Moreover,neitherinterventionhadasignificant
influenceonall-causehospitalizationsordeathat6or12months.These2studies48,49alsodiffered
fromourstudyinseveralways.OurstudywasfocusedonincreasingPAandprioritizing
generalizabilitybyrandomizingallpatientswhohadanyCOPD-relatedacutecareeventinthe
previous12months,withfewexclusions,relyingsolelyonEMRdatawithoutperformingmedical
recordreviews.Incontrast,these2efficacystudies48,49conductedextensivemedicalrecordreviews
andscreeningsbeforerecruitingpatients,whiletheywerestillhospitalized,andultimatelyenrolled
andrandomized22%to30%oflikelythemostmotivatedpatients.AcceptabilityofWOtopatients
andlevelofparticipationareessentialcomponentsofthereal-worldeffectiveness.Iftrialenrollment
waslimitedtothosewhovolunteered,findingsregardinginterventionacceptabilityoradherenceat
Table3.LogisticRegressionAnalysesoftheWalkOn!InterventiononthePrimaryCompositeOutcome
ofAll-CauseHospitalizations,ObservationStays,EmergencyDepartmentVisits,andDeath
Participants,No.(%) OR(95%CI)
HealthCareUseorDeath StandardCare WalkOn! Unadjusted Adjusted
PrimaryIntent-to-TreatAnalysis:Follow-upfor12moAfterRandomizationa
No. 1349 1358 NA NA
All-causeacutecareuseand 864(64.0) 883(65.0) 1.04(0.89-1.22) 1.09(0.92-1.28)
death
Hospitalizations 499(37.0) 502(36.9) 1.00(0.85-1.17) 1.05(0.89-1.24)
Observationstays 269(19.9) 295(21.7) 1.11(0.93-1.34) 1.13(0.93-1.37)
Emergencydepartmentvisits 694(51.4) 702(51.7) 1.01(0.87-1.17) 1.03(0.88-1.20)
Death 117(8.7) 117(8.6) 0.99(0.76-1.30) 1.02(0.77-1.36)
COPD-relatedacutecareuseb 398(29.5) 411(30.3) 1.04(0.88-1.22) 1.10(0.93-1.31)
Prespecified,As-Treated,IPTWAnalysis:Follow-upfor2-12moAfterRandomizationc
No. 1310d 321 NA NA
All-causeacutecareuseand 781(59.6) 185(57.6) 0.92(0.72-1.18) 1.05(0.82-1.35)
death
Hospitalizations 433(33.1) 91(28.3) 0.80(0.61-1.05) 0.84(0.65-1.10)
Observationstays 230(17.6) 53(16.5) 0.93(0.67-1.29) 0.92(0.66-1.28)
Emergencydepartmentvisits 610(46.6) 144(44.9) 0.93(0.72-1.19) 1.07(0.84-1.36)
Death 95(7.3) 13(4.0) 0.54(0.30-0.98) 0.62(0.35-1.11)
COPD-relatedacutecareuseb 195(14.9) 48(15.0) 1.01(0.71-1.42) 0.96(0.68-1.35)
Abbreviations:COPD,chronicobstructivepulmonarydisease;IPTW,inverseprobabilityoftreatmentweighting;NA,not
applicable;OR,oddsratio.
aIntenttotreat:adjustedORsarefromlogisticregressionmodelsthatincludedage,forcedexpiratoryvolumeinthefirst
secondofexpirationpredicted,CharlsonComorbidityIndex,oxygenuse,hospitalizationforCOPDintheprevious12
months,outpatient-treatedCOPDexacerbationintheprevious12months,lengthoftimesinceacutecareuseto
randomization,useoflong-actingβ-2agonistorinhaledcorticosteroids,physicalactivitylevel,andstudysite.
bTheCOPD-relatedacutecareuseincludeshospitalizations,observationstays,andemergencydepartmentvisitsfor
COPDexacerbations.
cAstreated:adjustedORsarefromlogisticregressionmodelsthatincludedstabilizedpropensityscoreIPTWtobalance
baselinecharacteristics(sociodemographics,healthbehaviors,diseaseseverity,comorbidities,inhalers/medications,and
healthcareuseintheprioryear)betweenpatientswhoparticipatedinWalkOn!andthestandardcaregroup.
dStandardcarepatientsnotincludedintheas-treatedanalysiswereduetodisenrollment(n=17)anddeaths(n=22)in
thefirst2monthsafterrandomization.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 9/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
thepopulationlevelwouldhavelimitedscientificvalueandclinicaloperationsutilityforhealth
systemsintheirdecisiontoinvestinsuchprograms.
WhileWOparticipationfellshortofourtarget,the23.6%(321of1358)uptakeisconsiderable
whencontrastedwithparticipationinPRbyMedicarebeneficiaries(4%)withCOPD13oramong
thosewhohadarecentCOPDhospitaldischarge(2.7%)12oramongpatientsexposedtolighter-
touchno-costbehavioralprograms(2%).50Nonetheless,healthsystemsneedtoweighthe
resourcesassociatedwithbroadoutreacheffortsandtheyieldinpatientengagement,especiallyin
responsetotherecentPAguidelinesrecommendingthatallolderadultsandthosewithchronic
conditionsengageinsomelevelofPA.16Whencontacted,approximately34.6%(471of1358)of
patientsinourstudyexpressednointerestintheWOprogram.However,therateofdisinterested
patientswouldincreaseto57.7%(784of1358)ifpassivedeclines(patientswhodidnotreturnour
callsdespite3contacts)wereincluded.Withmorepersuasiveadvicefromexistingtrustedhealth
careprofessionalsvstheconstrainedrecruitmentconsentinglanguagerequiredofresearchstudies,
itispossiblethatparticipationinprogramslikeWOmightbehigher.Alternatively,ourexperience
maybeasgoodasitgets,whereuptoone-halfofthetargetpopulationmaynotbeactivatedand
maychoosenottoengageinanyPAoutreacheffortsduetoothercompetingpriorities.Better
methodsforidentifyingactivatedpatientswhoarecontemplatingchangeareneededtoyielda
higherreturn.
TheWOinterventionhadafavorableeffectontheprocessoutcomeofPA(capturedinroutine
careforallpatients),asreflectedbyagreaterproportionofWOparticipantsreportingengagementin
anyPAoratleast150minutesperweekofPA(meetingnationalguidelines16)comparedwith
controls.ArecentEuropeanstudy20testingasimilarPAinterventionalsofoundsignificant
improvementsinPAintheas-treatedanalysesbutnotintheITTanalyses.Inaddition,therewere
modestbutsignificantimprovementsinthePROMIS-10physicalhealthdomainandsedentarytime
amongWOparticipantsat6monthscomparedwithasubsetofcontrolsurveyrespondents,butthis
effectdissipatedby12monthsduetodecreasedengagementovertime,acommonobservationthat
Table4.Patient-ReportedOutcomesChangeScoresFromBaselineto6Monthsand12Months
WalkOn!Participants StandardCareSurveyResponders
Baseline, MeanChange Baseline, MeanChange Difference(95%CI)
Outcomea No. Mean(SD) FromBaseline No. Mean(SD) FromBaseline BetweenChangeScores PValue EffectSize(95%CI)
CAT,↓0-40
6mo 197 18.4(7.4) −0.44 193 20.3(8.3) −0.38 −0.06(−1.3to1.19) .93 −0.01(−0.21to0.19)
12mo 188 18.0(7.3) −0.15 171 20.5(8.5) −0.56 0.41(−0.92to1.72) .55 0.06(−0.14to0.27)
PHQ-8,↓0-24
6mo 186 5.1(4.4) −0.56 188 6.5(5.8) −0.56 0.00(−0.83to0.86) .97 0.00(−0.20to0.21)
12mo 183 4.9(4.2) −0.06 164 6.6(6.0) −0.30 0.24(−0.67to1.14) .60 0.06(−0.16to0.27)
GAD-7,↓0-21
6mo 187 4.2(4.2) −0.23 185 5.4(5.8) −0.39 0.16(−0.71to1.03) .72 0.04(−0.17to0.24)
12mo 184 4.0(4.1) −0.21 164 5.2(5.8) −0.63 0.43(−0.42to1.28) .32 0.11(−0.11to0.32)
PROMIS-10MentalHealth,21-68↑
6mo 195 47.8(8.5) −0.26 196 45.6(9.2) 0.40 −0.67(−2.01to0.67) .33 −0.10(−0.30to0.10)
12mo 189 47.7(8.8) 0.26 172 45.3(8.9) 0.69 −0.43(−1.9to1.03) .56 −0.06(−0.27to0.15)
PROMIS-10PhysicalHealth,16-68↑
6mo 195 41.0(6.7) 1.01 196 40.0(8.4) −0.44 1.45(0.29to2.60) .01 0.25(0.05to0.45)
12mo 189 40.7(7.0) 0.97 172 39.8(8.6) 0.49 0.48(−0.84to1.79) .47 0.08(−0.13to0.28)
SedentaryTime,h/db
6mo 172 4.7(3.1) −0.67 158 5.1(3.8) 0.08 −0.75(−1.39to−0.12) .02 −0.26(−0.48to−0.04)
12mo 169 4.8(3.0) −0.31 140 5.2(3.9) −0.07 −0.24(−0.93to0.45) .50 −0.08(−0.30to0.15)
Abbreviations:CAT,COPDAssessmentTest;GAD-7,GeneralizedAnxietyDisorder7; bSedentarytimeisbasedonthefollowing:“Inthelast7days,pleaseestimatethetime
PHQ-8,PatientHealthQuestionnaire8;PROMIS-10,Patient-ReportedOutcomes youspentwatchingTVorvideosonatypicalday.”
MeasurementInformationSystem10.
aArrowsindicatedirectionofbetterscores.
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 10/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
issimilartopreviousPAstudies.18,51Together,thesefindingssuggestthatthePAcoaching
interventionpositivelyaffectedself-reportedPA,inactivity,andphysicalqualityoflifebutmaynot
havebeenofsufficientdoseacrossthetargetpopulation(andwithlimitedpower)tohavea
significant,consistentinfluenceonmoredistaloutcomesofacutecareuseandsurvival,asseenin
theas-treatedanalyses.
Anearlierobservationalstudy52examiningPAintensityanddurationusingaccelerometerdata
foundthatlow-intensityPAhadaprotectiveeffectonriskofCOPDhospitalization,withnobenefit
fromhigh-intensityPA.Infact,forevery1000-stepincreaseinlow-intensityPA,therewasa20%risk
reductioninCOPDhospitalizations.52Inourstudy,althoughtheriskestimatefortheas-treated
analysisofCOPD-relatedacutecareusewasinafavorabledirection,thesignificantfindingwith
all-causeobservationstayssuggeststhatbeingphysicallyactivemaybeassociatedwithfewer,less
severehospitalencountersthatdonotrequireanadmission.Becauseuseofobservationstaysisa
newphenomenoninresponsetotheHospitalReadmissionsReductionProgram,thereislittle
publishedresearchonhowinterventionsaltertheseencountersinpatientswithCOPD.53-55
StrengthsandLimitations
Thereareseveralstrengthstoourstudy.Toourknowledge,thisisthefirstlarge-scale,healthsystems
efforttoengageadiverseandbroadlyrepresentativesampleofpatientsathighriskforrecurrent
COPDexacerbationstoaddressakeyquestionofuptakeandlong-termeffectivenessofascalable
andaffordableapproachtoPApromotion.TheWOinterventionwasintentionallydesignedtobe
easilyintegratedinpatients’dailylives.ThistailoredapproachofencouragingincreasedPAbasedon
individualneedsandpreferencesisalsoconsistentwiththeprimaryPAguideline
recommendations.16
Ourstudyalsohadlimitations.Giventheneedforautomatedidentificationandrandomization
ofeligiblepatientsusingEMRdatatoensurebroadestrepresentation,wecouldnotrelyon
spirometryasaninclusioncriterionandmayhaveincludedsomepatientswithoutCOPD.More
importantly,ourgoalwastoalignwiththereal-worldpolicyandpractice,relyingsolelyonthe
administrativeandclinicaldatafromtheEMRstoidentifyeligiblepatients.56However,ourdecision
tobebroadlyinclusiveofpatientswhomayhavebeenexperiencingrapiddeclineintheirhealthand
whomayhavenotbenefitedfromtheinterventionlikelycontributedtothelowuptakeand
engagementovertime.
Despiteourattemptstoaccommodatepatientpreferencesbyofferingandintegratingthe3
activitysensorsintooursystem,themultipletechnicalchallengeswiththedeviceslikelycontributed
todisengagementbysomeparticipantseventhoughthecoachesencouragedpatientstoprioritize
accumulatingPAtimeinsteadoftheirstepcountswhentheyhadtechnicaldifficulties.Whilethe
individualizedWOinterventionmaybeperceivedasbeingtooheterogeneous,notbeingintensiveor
multifaceted,ornothavingrigorousfidelitycontrol,thegoalofthestudywastoworkwithinthe
real-worldconstraintstotestascalableandaffordableapproachtopromotingPAusingexisting
frontlineclinicalstaff.Wereliedontheexercisevitalsign,aself-reportedmeasureobtainedfrom
routinecare,asakeyprocessoutcomebecauseitwasnotpracticaltomeasureobjectivePAacross
allpatients.Thehighlevelofmissingnessinthepatient-reportedoutcomesandthemultiple
comparisonssuggestcautionininterpretingthesignificantPROMIS-10findings.Despiteourefforts
toadjustforselectionbiasintheas-treatedanalyses,residualconfoundingisanimportantlimitation.
Thestudydrawsfromapopulationofinsuredpatientsfromanintegratedsystem,potentially
limitinggeneralizability.ComparedwithotherrecentlypublishedCOPDstudies,48ourstudysample
appearedtobealreadyoptimizedwiththeirCOPD,cardiovascular,anddiabeticcare,asreflectedin
theprescribedinhalersandcardiometabolicmarkers,withpotentiallylittleroomforadditional
change.Thisiswellillustratedwiththeattenuatedeffectsofcardiacrehabilitationondeathand
cardiaceventsinrecenttrialscomparedwithearlierstudies,likelyduetotherapeuticadvances.57
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 11/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
Conclusions
InthispragmaticrandomizedclinicaltrialofpatientsathighriskforrecurrentCOPDexacerbations,a
potentiallyscalableandsustainable12-monthPAcoachinginterventionwasassociatedwith
increasedself-reportedPAandmodestimprovementsinthePROMIS-10physicalqualityoflife
domainbuthadnosignificanteffectsontheprimarycompositeoutcomeofacutecareuseanddeath
forbothas-treatedanalysesandITTanalyses.Findingsfromthisstudycallformorerealistic
expectationsforfrail,olderpatientswithseriouschronicconditionstoengageinandmeetPA
recommendationsandforincreasedPAtohaveaninfluenceondistaloutcomes.Futuremethods
workisneededtomoreefficientlyidentifyactivatedpatientsforbehavioralinterventions.
ARTICLEINFORMATION
AcceptedforPublication:July1,2019.
Published:August16,2019.doi:10.1001/jamanetworkopen.2019.9657
OpenAccess:ThisisanopenaccessarticledistributedunderthetermsoftheCC-BYLicense.©2019NguyenHQ
etal.JAMANetworkOpen.
CorrespondingAuthor:HuongQ.Nguyen,PhD,RN,DepartmentofResearchandEvaluation,KaiserPermanente
SouthernCalifornia,100SLosRoblesAve,SecondFloor,Pasadena,CA91101(huong.q2.nguyen@kp.org).
AuthorAffiliations:DepartmentofResearchandEvaluation,KaiserPermanenteSouthernCalifornia,Pasadena
(Nguyen,Liu,Gould,Towner,Lee,Park,Xiang);HarvardMedicalSchool,Boston,Massachusetts(Moy);VABoston
HealthcareSystem,Boston,Massachusetts(Moy);UniversityofWashington,Seattle(Fan);VAPugetSoundHealth
CareSystem,Seattle,Washington(Fan);KaiserPermanenteSouthernCalifornia,SanDiego(Desai);Kaiser
PermanenteSouthernCalifornia,OrangeCounty,Anaheim(Yuen).
AuthorContributions:DrNguyenhadfullaccesstoallofthedatainthestudyandtakesresponsibilityforthe
integrityofthedataandtheaccuracyofthedataanalysis.
Conceptanddesign:Nguyen,Desai,Towner,Xiang.
Acquisition,analysis,orinterpretationofdata:Nguyen,Moy,Liu,Fan,Gould,Desai,Yuen,Lee,Park,Xiang.
Draftingofthemanuscript:Nguyen,Liu,Fan,Towner,Lee,Park.
Criticalrevisionofthemanuscriptforimportantintellectualcontent:Nguyen,Moy,Liu,Fan,Gould,Desai,Towner,
Yuen,Xiang.
Statisticalanalysis:Nguyen,Moy,Liu,Lee,Xiang.
Obtainedfunding:Nguyen,Xiang.
Administrative,technical,ormaterialsupport:Nguyen,Yuen,Park.
Supervision:Nguyen,Desai,Towner,Xiang.
ConflictofInterestDisclosures:DrNguyenreportedreceivinggrantsfromthePatient-CenteredOutcomes
ResearchInstitute(PCORI).DrMoyreportedreceivingpersonalfeesfromAstraZeneca.DrFanreportedreceiving
grantsfromPCORI,DepartmentofVeteransAffairs,NationalInstitutesofHealth,andFirlandFoundation.DrGould
reportedreceivinggrantsfromPCORI.DrTownerreportedreceivinggrantsfromPCORI,Gilead,ViiVHealthcare,
andMerck.DrXiangreportedreceivinggrantsfromPCORI.Nootherdisclosureswerereported.
Funding/Support:ThisworkwassupportedthroughPCORIaward1403-14117(DrNguyen).
RoleoftheFunder/Sponsor:Thefundingsourcehadnoroleinthedesignandconductofthestudy;collection,
management,analysis,andinterpretationofthedata;preparation,review,orapprovalofthemanuscript;and
decisiontosubmitthemanuscriptforpublication.
Disclaimer:Allstatementsinthisreport,includingitsfindingsandconclusions,aresolelythoseoftheauthorsand
donotnecessarilyrepresenttheviewsofPCORI,itsboardofgovernors,ormethodologycommittee.
MeetingPresentation:ThisstudywaspresentedattheAmericanThoracicSociety2019International
Conference;May20,2019;Dallas,Texas.
DataSharingStatement:SeeSupplement3.
AdditionalContributions:Weacknowledgeourmultiplestakeholderswhohavecontributedtothedesignand
implementationofthisresearchstudy:(1)patientadvisoryboardmembers(AdrienneBailey[deceased],Susan
Barlett,RetaCoulombe,KennethDesjardins[deceased],RonaldFox[deceased],GloriaJohnson,FreidaMiller,
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 12/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
BonnieTomeoni,andLesliePaskus),(2)KaiserPermanenteSouthernCaliforniaphysicalactivitycoaches(Julie
Armstrong,RRT,ErikaBritton,AugustoCam,RRT,AnnaDeLeon,AnnetteGregson,RRT,FerdinandValmonte,
MichelleIsom,SallyLeung,MaidaLowery,EdithMedina,OlgaRodriguez,andWilliamValenson),(3)Kaiser
PermanenteSouthernCaliforniapulmonarychiefs(LarryTom,MD,CindyPak,MD,DavidSuh,MD,CraigArakaki,
MD,StevenLee,MD,ThomasMahrer,MD,MichaelMarkman,MD,VijiSankar,MD,NikhilShah,MD,andGeorge
Yuen,MD),(4)KaiserPermanenteSouthernCaliforniaadministratorsandoperationalleaders(JeffWeaver,
ShaylynnBuffum,GuillermoFriederichsen,TheodoreFuertes,HectorGarcia,BrianGardner,JoeQuiroz,Antony
Saenz,JerrySaldana,SteveCedrone,andDebbieDaclan),and(5)KaiserPermanenteSouthernCalifornia
executivesponsors(MichaelKanter,MD,andBenjaminBroder,MD).Wealsoacknowledgethecontributionsofour
studyparticipantsandourdataandsafetymonitoringboardmembers:DavidAu,MD(UniversityofWashington),
KevinCain,PhD(UniversityofWashington),andBarbaraSternfeld,PhD(KaiserPermanenteNorthernCalifornia).
Thepatientadvisoryboardmembersandthedataandsafetymonitoringboardmemberswerecompensatedfor
theirparticipationandcontributionstothestudy.
REFERENCES
1. HeronM.Deaths:leadingcausesfor2016.NatlVitalStatRep.2018;67(6):1-77.
2. BiswasA,OhPI,FaulknerGE,etal.Sedentarytimeanditsassociationwithriskfordiseaseincidence,mortality,
andhospitalizationinadults:asystematicreviewandmeta-analysis.AnnInternMed.2015;162(2):123-132.doi:10.
7326/M14-1651
3. Garcia-AymerichJ,LangeP,BenetM,SchnohrP,AntóJM.Regularphysicalactivityreduceshospitaladmission
andmortalityinchronicobstructivepulmonarydisease:apopulationbasedcohortstudy.Thorax.2006;61(9):
772-778.doi:10.1136/thx.2006.060145
4. Garcia-RioF,RojoB,CasitasR,etal.Prognosticvalueoftheobjectivemeasurementofdailyphysicalactivityin
patientswithCOPD.Chest.2012;142(2):338-346.doi:10.1378/chest.11-2014
5. VaesAW,Garcia-AymerichJ,MarottJL,etal.Changesinphysicalactivityandall-causemortalityinCOPD.Eur
RespirJ.2014;44(5):1199-1209.doi:10.1183/09031936.00023214
6. WaschkiB,KirstenA,HolzO,etal.Physicalactivityisthestrongestpredictorofall-causemortalityinpatients
withchronicobstructivepulmonarydisease:aprospectivecohortstudy.Chest.2011;140(2):331-342.doi:10.1378/
chest.10-2521
7. WaschkiB,KirstenAM,HolzO,etal.Diseaseprogressionandchangesinphysicalactivityinpatientswith
chronicobstructivepulmonarydisease.AmJRespirCritCareMed.2015;192(3):295-306.doi:10.1164/rccm.
201501-0081OC
8. MoyML,TeylanM,WestonNA,GagnonDR,GarshickE.DailystepcountpredictsacuteexacerbationsinaUS
cohortwithCOPD.PLoSOne.2013;8(4):e60400.doi:10.1371/journal.pone.0060400
9. NguyenHQ,ChuL,AmyLiuIL,etal.Associationsbetweenphysicalactivityand30-dayreadmissionriskin
chronicobstructivepulmonarydisease.AnnAmThoracSoc.2014;11(5):695-705.doi:10.1513/AnnalsATS.
201401-017OC
10. SpruitMA,SinghSJ,GarveyC,etal;ATS/ERSTaskForceonPulmonaryRehabilitation.AnofficialAmerican
ThoracicSociety/EuropeanRespiratorySocietystatement:keyconceptsandadvancesinpulmonary
rehabilitation.AmJRespirCritCareMed.2013;188(8):e13-e64.doi:10.1164/rccm.201309-1634ST
11. McCarthyB,CaseyD,DevaneD,MurphyK,MurphyE,LacasseY.Pulmonaryrehabilitationforchronic
obstructivepulmonarydisease.CochraneDatabaseSystRev.2015;(2):CD003793.
12. SpitzerKA,StefanMS,PriyaA,etal.Participationinpulmonaryrehabilitationafterhospitalizationforchronic
obstructivepulmonarydiseaseamongMedicarebeneficiaries.AnnAmThoracSoc.2019;16(1):99-106.doi:10.1513/
AnnalsATS.201805-332OC
13. NishiSP,ZhangW,KuoYF,SharmaG.Pulmonaryrehabilitationutilizationinolderadultswithchronic
obstructivepulmonarydisease,2003to2012.JCardiopulmRehabilPrev.2016;36(5):375-382.doi:10.1097/HCR.
0000000000000194
14. RochesterCL,VogiatzisI,HollandAE,etal;ATS/ERSTaskForceonPolicyinPulmonaryRehabilitation.An
officialAmericanThoracicSociety/EuropeanRespiratorySocietypolicystatement:enhancingimplementation,
use,anddeliveryofpulmonaryrehabilitation.AmJRespirCritCareMed.2015;192(11):1373-1386.doi:10.1164/rccm.
201510-1966ST
15. RobinsonH,WilliamsV,CurtisF,BridleC,JonesAW.Facilitatorsandbarrierstophysicalactivityfollowing
pulmonaryrehabilitationinCOPD:asystematicreviewofqualitativestudies.NPJPrimCareRespirMed.2018;
28(1):19.doi:10.1038/s41533-018-0085-7
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 13/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
16. PiercyKL,TroianoRP,BallardRM,etal.ThePhysicalActivityGuidelinesforAmericans.JAMA.2018;320(19):
2020-2028.doi:10.1001/jama.2018.14854
17. JhaAK.Tofixthehospitalreadmissionsprogram,prioritizewhatmatters.JAMA.2018;319(5):431-433.doi:10.
1001/jama.2017.21623
18. CoultasDB,JacksonBE,RussoR,etal.Alifestylephysicalactivityinterventionforpatientswithchronic
obstructivepulmonarydisease:arandomizedcontrolledtrial.AnnAmThoracSoc.2016;13(5):617-626.doi:10.
1513/AnnalsATS.201508-508OC
19. CoultasDB,JacksonBE,RussoR,etal.Home-basedphysicalactivitycoaching,physicalactivity,andhealth
careutilizationinchronicobstructivepulmonarydisease:ChronicObstructivePulmonaryDiseaseSelf-
ManagementActivationResearchTrialsecondaryoutcomes.AnnAmThoracSoc.2018;15(4):470-478.doi:10.
1513/AnnalsATS.201704-308OC
20. Arbillaga-EtxarriA,Gimeno-SantosE,Barberan-GarciaA,etal.Long-termefficacyandeffectivenessofa
behaviouralandcommunity-basedexerciseintervention(UrbanTraining)toincreasephysicalactivityinpatients
withCOPD:arandomisedcontrolledtrial.EurRespirJ.2018;52(4):1800063.doi:10.1183/13993003.00063-2018
21. LahhamA,McDonaldCF,HollandAE.Exercisetrainingaloneorwiththeadditionofactivitycounseling
improvesphysicalactivitylevelsinCOPD:asystematicreviewandmeta-analysisofrandomizedcontrolledtrials.
IntJChronObstructPulmonDis.2016;11:3121-3136.doi:10.2147/COPD.S121263
22. LeidyNK,KimelM,AjagbeL,KimK,HamiltonA,BeckerK.Designingtrialsofbehavioralinterventionsto
increasephysicalactivityinpatientswithCOPD:insightsfromthechronicdiseaseliterature.RespirMed.2014;108
(3):472-481.doi:10.1016/j.rmed.2013.11.011
23. MoyML,CollinsRJ,MartinezCH,etal.AnInternet-mediatedpedometer-basedprogramimproveshealth-
relatedquality-of-lifedomainsanddailystepcountsinCOPD:arandomizedcontrolledtrial.Chest.2015;148(1):
128-137.doi:10.1378/chest.14-1466
24. NguyenHQ,DoneskyD,ReinkeLF,etal.Internet-baseddyspneaself-managementsupportforpatientswith
chronicobstructivepulmonarydisease.JPainSymptomManage.2013;46(1):43-55.doi:10.1016/j.jpainsymman.
2012.06.015
25. NguyenHQ,GillDP,WolpinS,SteeleBG,BendittJO.Pilotstudyofacellphone–basedexercisepersistence
interventionpost-rehabilitationforCOPD.IntJChronObstructPulmonDis.2009;4:301-313.doi:10.2147/
COPD.S6643
26. NguyenHQ,Carrieri-KohlmanV,RankinSH,SlaughterR,StulbargMS.IsInternet-basedsupportfordyspnea
self-managementinpatientswithCOPDpossible?resultsofapilotstudy.HeartLung.2005;34(1):51-62.doi:10.
1016/j.hrtlng.2004.06.005
27. MoyML,WestonNA,WilsonEJ,HessML,RichardsonCR.ApilotstudyofanInternetwalkingprogramand
pedometerinCOPD.RespirMed.2012;106(9):1342-1350.doi:10.1016/j.rmed.2012.06.013
28. BanduraA.SocialFoundationsofThoughtandAction:ASocialCognitiveTheory.EnglewoodCliffs,NJ:
PrenticeHall;1986.
29. ClarkNM,GongM,KacirotiN.Amodelofself-regulationforcontrolofchronicdisease.HealthEducBehav.
2001;28(6):769-782.doi:10.1177/109019810102800608
30. ClarkNM,ZimmermanBJ.Asocialcognitiveviewofself-regulatedlearningabouthealth.HealthEducRes.
1990;5(3):371-379.doi:10.1093/her/5.3.371
31. MillerWR,RollnickS.MotivationalInterviewing.2nded.NewYork,NY:GuilfordPress;2002.
32. LoudonK,TreweekS,SullivanF,DonnanP,ThorpeKE,ZwarensteinM.ThePRECIS-2tool:designingtrialsthat
arefitforpurpose.BMJ.2015;350:h2147.doi:10.1136/bmj.h2147
33. ThorpeKE,ZwarensteinM,OxmanAD,etal.Apragmatic-explanatorycontinuumindicatorsummary
(PRECIS):atooltohelptrialdesigners.CMAJ.2009;180(10):E47-E57.doi:10.1503/cmaj.090523
34. LiuIL,MoyM,EstradaE,RippbergerE,NguyenHQ.An“exercisevitalsign”isavalidproxymeasureofphysical
activityinCOPDinroutineclinicalcare.TranslJAmCollSportsMed.2017;2(23):148-152.
35. AdamsonJ,CockayneS,PufferS,TorgersonDJ.Reviewofrandomisedtrialsusingthepost-randomised
consent(Zelen’s)design.ContempClinTrials.2006;27(4):305-319.doi:10.1016/j.cct.2005.11.003
36. ZelenM.Anewdesignforrandomizedclinicaltrials.NEnglJMed.1979;300(22):1242-1245.doi:10.1056/
NEJM197905313002203
37. NguyenHQ,BaileyA,ColemanKJ,etal.Patient-centeredphysicalactivitycoachinginCOPD(WalkOn!):
astudyprotocolforapragmaticrandomizedcontrolledtrial.ContempClinTrials.2016;46:18-29.doi:10.1016/j.cct.
2015.10.010
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 14/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
38. NguyenHQ,MoyML,FanVS,etal.Applyingthepragmatic-explanatorycontinuumindicatorsummarytothe
implementationofaphysicalactivitycoachingtrialinchronicobstructivepulmonarydisease.NursOutlook.
2018;66(5):455-463.doi:10.1016/j.outlook.2018.05.005
39. WalkerPP,BurnettA,FlavahanPW,CalverleyPM.LowerlimbactivityanditsdeterminantsinCOPD.Thorax.
2008;63(8):683-689.doi:10.1136/thx.2007.087130
40. JonesPW,HardingG,BerryP,WiklundI,ChenWH,KlineLeidyN.Developmentandfirstvalidationofthe
COPDAssessmentTest.EurRespirJ.2009;34(3):648-654.doi:10.1183/09031936.00102509
41. KroenkeK,SpitzerR.ThePHQ-9:anewdepressiondiagnosticandseveritymeasure.PsychiatrAnn.2002;32
(9):1-7.doi:10.3928/0048-5713-20020901-06
42. SpitzerRL,KroenkeK,WilliamsJB,LöweB.Abriefmeasureforassessinggeneralizedanxietydisorder:the
GAD-7.ArchInternMed.2006;166(10):1092-1097.doi:10.1001/archinte.166.10.1092
43. HaysRD,BjornerJB,RevickiDA,SpritzerKL,CellaD.Developmentofphysicalandmentalhealthsummary
scoresfromthePatient-ReportedOutcomesMeasurementInformationSystem(PROMIS)globalitems.QualLife
Res.2009;18(7):873-880.doi:10.1007/s11136-009-9496-9
44. MoyML,GouldMK,LiuIA,LeeJS,NguyenHQ.Physicalactivityassessedinroutinecarepredictsmortality
afteraCOPDhospitalisation.ERJOpenRes.2016;2(1):00062-2015.doi:10.1183/23120541.00062-2015
45. BourbeauJ,JulienM,MaltaisF,etal;ChronicObstructivePulmonaryDiseaseAxisoftheRespiratoryNetwork
FondsdelaRechercheenSantéduQuébec.Reductionofhospitalutilizationinpatientswithchronicobstructive
pulmonarydisease:adisease-specificself-managementintervention.ArchInternMed.2003;163(5):585-591.doi:
10.1001/archinte.163.5.585
46. RiceKL,DewanN,BloomfieldHE,etal.Diseasemanagementprogramforchronicobstructivepulmonary
disease:arandomizedcontrolledtrial.AmJRespirCritCareMed.2010;182(7):890-896.doi:10.1164/rccm.
200910-1579OC
47. AustinPC,StuartEA.Movingtowardsbestpracticewhenusinginverseprobabilityoftreatmentweighting
(IPTW)usingthepropensityscoretoestimatecausaltreatmenteffectsinobservationalstudies.StatMed.2015;
34(28):3661-3679.doi:10.1002/sim.6607
48. AboumatarH,NaqibuddinM,ChungS,etal.Effectofaprogramcombiningtransitionalcareandlong-term
self-managementsupportonoutcomesofhospitalizedpatientswithchronicobstructivepulmonarydisease:
arandomizedclinicaltrial.JAMA.2018;320(22):2335-2343.doi:10.1001/jama.2018.17933
49. BenzoR,VickersK,NovotnyPJ,etal.Healthcoachingandchronicobstructivepulmonarydisease
rehospitalization:arandomizedstudy.AmJRespirCritCareMed.2016;194(6):672-680.doi:10.1164/rccm.201512-
2503OC
50. XiaoH,AdamsSR,GolerN,etal.Wellnesscoachingforpeoplewithprediabetes:arandomized
encouragementtrialtoevaluateoutreachmethodsatKaiserPermanente,NorthernCalifornia,2013.PrevChronic
Dis.2015;12:E207.doi:10.5888/pcd12.150251
51. MoyML,MartinezCH,KadriR,etal.Long-termeffectsofanInternet-mediatedpedometer-basedwalking
programforchronicobstructivepulmonarydisease:randomizedcontrolledtrial.JMedInternetRes.2016;18
(8):e215.doi:10.2196/jmir.5622
52. Donaire-GonzalezD,Gimeno-SantosE,BalcellsE,etal;PAC-COPDStudyGroup.Benefitsofphysicalactivity
onCOPDhospitalisationdependonintensity.EurRespirJ.2015;46(5):1281-1289.doi:10.1183/13993003.
01699-2014
53. AlbrittonJ,BelnapTW,SavitzLA.TheeffectoftheHospitalReadmissionsReductionProgramonreadmission
andobservationstayratesforheartfailure.HealthAff(Millwood).2018;37(10):1632-1639.doi:10.1377/hlthaff.
2018.0064
54. ZuckermanRB,SheingoldSH,OravEJ,RuhterJ,EpsteinAM.Readmissions,observation,andtheHospital
ReadmissionsReductionProgram.NEnglJMed.2016;374(16):1543-1551.doi:10.1056/NEJMsa1513024
55. SabbatiniAK,WrightB.Excludingobservationstaysfromreadmissionrates:whatqualitymeasuresare
missing.NEnglJMed.2018;378(22):2062-2065.doi:10.1056/NEJMp1800732
56. CentersforMedicare&MedicaidServices.HospitalReadmissionsReductionProgram(HRRP).http://www.cms.
gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html.
AccessedDecember31,2018.
57. AndersonL,OldridgeN,ThompsonDR,etal.Exercise-basedcardiacrehabilitationforcoronaryheartdisease:
Cochranesystematicreviewandmeta-analysis.JAmCollCardiol.2016;67(1):1-12.doi:10.1016/j.jacc.2015.10.044
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 15/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | PulmonaryMedicine EffectofPhysicalActivityCoachinginChronicObstructivePulmonaryDisease
SUPPLEMENT1.
TrialProtocol
SUPPLEMENT2.
eMethods.AdditionalStatisticalAnalysisInformation
eTable1.AdditionalBaselineCharacteristics
eTable2.WalkOn!ParticipantsProcessandSatisfactionMeasures
eTable3.Time-to-EventAnalysesoftheWalkOn!InterventiononthePrimaryCompositeOutcomeofAll-Cause
Hospitalizations,ObservationStays,EmergencyDepartmentVisits,andDeath
eTable4.Cardio-metabolicMarkersPost-randomization
eFigure1.StepsperDayChangeOver12MonthsforWalkOn!ParticipantsWhoSharedTheirData,byLevelof
FunctioningatBaseline
eFigure2.Intent-to-TreatAdjustedTime-to-EventAnalysesoftheWalkOn!InterventiononthePrimary
CompositeOutcomeofAll-CauseHospitalizations,ObservationStays,EmergencyDepartmentVisits,andDeath
12-MonthsPost-randomization
eFigure3.As-TreatedAdjustedTime-to-EventAnalysesoftheWalkOn!InterventiononthePrimaryComposite
OutcomeofAll-CauseHospitalizations,ObservationStays,EmergencyDepartmentVisits,andDeathfromMonths
2-12Post-randomization
SUPPLEMENT3.
DataSharingStatement
JAMANetworkOpen.2019;2(8):e199657.doi:10.1001/jamanetworkopen.2019.9657 (Reprinted) August16,2019 16/16
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
